Moderna Inc
Trump’s tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks
Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump’s goal of bringing manufacturing back to the United States has put the industry in the administration’s crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated […]
Read More
Stocks making the biggest moves midday: CoreWeave, Canada Goose, Tesla, United Airlines and more
Check out the companies making headlines in midday trading. CoreWeave — Shares of the cloud provider tumbled more than 9% in its second trading session since going public. CoreWeave, which rents out access to Nvidia graphics processing units to other large tech companies, suffered a disappointing debut last week. Nvidia also saw its shares drop […]
Read More
Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.
Rafael Henrique | Lightrocket | Getty Images Shares of major vaccine makers dropped on Monday after a key U.S. health official resigned in protest of Health and Human Services Secretary Robert F. Kennedy Jr.’s views on immunization. The departure of Peter Marks, the Food and Drug Administration’s top vaccine regulator, has raised fresh fears about […]
Read More
Most of the S&P 500 is already in correction territory as benchmark teeters near milestone
A trader works on the floor of the New York Stock Exchange (NYSE) at the opening bell in New York City on March 10, 2025. Charly Triballeau | Afp | Getty Images The majority of the stocks in the S&P 500 are already in correction territory as the sell-off on Wall Street continues to drag […]
Read More
Stocks making the biggest moves midday: General Motors, Novo Nordisk, Kenvue, CrowdStrike and more
Check out the companies making headlines in midday trading: Box — Shares declined more than 3% after the cloud storage company’s top-line guidance fell short of estimates. Box sees first-quarter revenue coming in between $274 million and $275 million, while analysts polled by LSEG expected $279.5 million. Box’s fourth-quarter revenue of $280 million exceeded Wall […]
Read More
Stocks making the biggest moves midday: General Motors, Novo Nordisk, Kenvue, CrowdStrike and more
Check out the companies making headlines in midday trading: Box — Shares declined more than 3% after the cloud storage company’s top-line guidance fell short of estimates. Box sees first-quarter revenue coming in between $274 million and $275 million, while analysts polled by LSEG expected $279.5 million. Box’s fourth-quarter revenue of $280 million exceeded Wall […]
Read More
OpenAI tops 400 million users despite DeepSeek’s emergence
Brad Lightcap of OpenAI. Courtesy: OpenAI OpenAI appears to be growing quickly despite increasing competition. The San Francisco-based tech company had 400 million weekly active users as of February, up 33% from 300 million in December, the company’s chief operating officer, Brad Lightcap, told CNBC. These numbers have not been previously reported. Lightcap pointed to […]
Read More
Stocks making the biggest moves midday: Intel, Walgreens Boots Alliance, Nike, Super Micro Computer and more
Check out the companies making headlines in midday trading. Super Micro Computer — The server builder surged 11%, extending its 32% rally from last week after CEO Charles Liang said he is “confident” the company can file its delayed annual report by the Feb. 25 deadline. Constellation Brands — The booze stock jumped 4.4% after […]
Read More
Stocks making the biggest moves premarket: Moderna, Airbnb, GameStop, Roku and more
Check out the companies making headlines before the bell: Moderna — The biotechnology company retreated 4% after losing $2.91 per share in the fourth quarter, a wider loss than the $2.68 expected by LSEG. However, the company beat expectations of analysts for revenue in the quarter. GameStop — Shares rallied 8% after sources familiar with […]
Read More
Moderna beats on revenue but loses more than expected as it scales down manufacturing
Moderna on Friday posted fourth-quarter revenue that beat estimates, but lost more than expected for the period, as the biotech company continues to slash costs and demand for its Covid vaccine falls. It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the rapid decline […]
Read More